BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17505030)

  • 1. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer.
    Tsuchiya T; Hashizume S; Akamine S; Muraoka M; Honda S; Tsuji K; Urabe S; Hayashi T; Yamasaki N; Nagayasu T
    Chest; 2007 Jul; 132(1):170-7. PubMed ID: 17505030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
    Goya T; Asamura H; Yoshimura H; Kato H; Shimokata K; Tsuchiya R; Sohara Y; Miya T; Miyaoka E;
    Lung Cancer; 2005 Nov; 50(2):227-34. PubMed ID: 16061304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
    Bergman P; Brodin D; Lewensohn R; de Petris L
    Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
    Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
    Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
    Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
    Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Suzuki M; Yoshida S; Tamura H; Wada H; Moriya Y; Hoshino H; Shibuya K; Yoshino I
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1031-6. PubMed ID: 19692261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of blood vessel invasion on prognosis of operated stage I non-small cell lung cancer patients.
    Turhan K; Samancilar O; Cagirici U; Goksel T; Nart D; Cakan A; Cok G
    Thorac Cardiovasc Surg; 2010 Feb; 58(1):28-31. PubMed ID: 20072973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.
    Pepek JM; Chino JP; Marks LB; D'amico TA; Yoo DS; Onaitis MW; Ready NE; Hubbs JL; Boyd J; Kelsey CR
    J Thorac Oncol; 2011 Apr; 6(4):757-61. PubMed ID: 21325975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
    Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
    Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations.
    Asamura H; Goya T; Koshiishi Y; Sohara Y; Tsuchiya R; Miyaoka E;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):316-9. PubMed ID: 16872956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
    Pfannschmidt J; Muley T; Bülzebruck H; Hoffmann H; Dienemann H
    Lung Cancer; 2007 Mar; 55(3):371-7. PubMed ID: 17123661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Chest; 2008 Mar; 133(3):662-9. PubMed ID: 17925418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
    Tsuchiya T; Akamine S; Muraoka M; Kamohara R; Tsuji K; Urabe S; Honda S; Yamasaki N
    Lung Cancer; 2007 Jun; 56(3):341-8. PubMed ID: 17350137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers.
    Fukui T; Mori S; Hatooka S; Shinoda M; Mitsudomi T
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1343-8. PubMed ID: 19026826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.